Tokyo Tape
Sign in
← Meiji Holdings

Quarterly report · Q1

2269.TEDINET S100RKR4
Period2023-04-01 → 2023-06-30
Filed2023-08-08
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
MetricValuePeriodScopeSource row
Revenue¥262.7bn2023-04-01 → 2023-06-30Cons.Net sales
Revenue¥1.06T2022-04-01 → 2023-03-31Cons.Net sales (5-year summary)
Revenue¥247.1bn2022-04-01 → 2022-06-30Cons.Net sales
Operating income¥19.5bn2023-04-01 → 2023-06-30Cons.Operating income
Operating income¥18.0bn2022-04-01 → 2022-06-30Cons.Operating income
Ordinary income¥19.2bn2023-04-01 → 2023-06-30Cons.Ordinary income
Ordinary income¥74.2bn2022-04-01 → 2023-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥18.4bn2022-04-01 → 2022-06-30Cons.Ordinary income
Profit before tax¥22.6bn2023-04-01 → 2023-06-30Cons.Income before income taxes
Profit before tax¥23.2bn2022-04-01 → 2022-06-30Cons.Income before income taxes
Net income (owners)¥11.6bn2023-04-01 → 2023-06-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥69.4bn2022-04-01 → 2023-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥16.0bn2022-04-01 → 2022-06-30Cons.Profit loss attributable to owners of parent
Net income¥12.5bn2023-04-01 → 2023-06-30Cons.Profit loss
Net income¥16.2bn2022-04-01 → 2022-06-30Cons.Profit loss
Total assets¥1.17Tat 2023-06-30Cons.Assets
Total assets¥1.14Tat 2023-03-31Cons.Assets
Total assets¥1.14Tat 2022-06-30Cons.Total assets (5-year summary)
Total liabilities¥409.7bnat 2023-06-30Cons.Liabilities
Total liabilities¥384.9bnat 2023-03-31Cons.Liabilities
Net assets / equity¥762.1bnat 2023-06-30Cons.Net assets
Net assets / equity¥751.3bnat 2023-03-31Cons.Net assets
Net assets / equity¥725.4bnat 2022-06-30Cons.Net assets (5-year summary)
Cash and deposits¥84.1bnat 2023-06-30Cons.Cash and deposits
Cash and deposits¥63.5bnat 2023-03-31Cons.Cash and deposits
Cash & equivalents¥81.0bnat 2023-06-30Cons.Cash and cash equivalents
Cash & equivalents¥60.9bnat 2023-03-31Cons.Cash and cash equivalents
Cash & equivalents¥84.9bnat 2022-06-30Cons.Cash and cash equivalents
Cash & equivalents¥64.9bnat 2022-03-31dCons.Cash and cash equivalents
Operating cash flow¥2.4bn2023-04-01 → 2023-06-30Cons.Net cash provided by used in operating activities
Operating cash flow¥85.0bn2022-04-01 → 2023-03-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥4.7bn2022-04-01 → 2022-06-30Cons.Net cash provided by used in operating activities
Investing cash flow−¥5.7bn2023-04-01 → 2023-06-30Cons.Net cash provided by used in investment activities
Investing cash flow−¥36.8bn2022-04-01 → 2023-03-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥9.0bn2022-04-01 → 2022-06-30Cons.Net cash provided by used in investment activities
Financing cash flow¥22.5bn2023-04-01 → 2023-06-30Cons.Net cash provided by used in financing activities
Financing cash flow−¥54.7bn2022-04-01 → 2023-03-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow¥22.3bn2022-04-01 → 2022-06-30Cons.Net cash provided by used in financing activities
EPS (basic)¥41.592023-04-01 → 2023-06-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥247.392022-04-01 → 2023-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥56.872022-04-01 → 2022-06-30Cons.Basic earnings loss per share (5-year summary)
Equity ratio61.6%at 2023-06-30Cons.Equity to asset ratio (5-year summary)
Equity ratio62.7%at 2023-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio60.0%at 2022-06-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 30
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2023-04-01 → 2023-06-30−¥151m
Reconciling Itemsreconcilingrevenue intersegment2023-04-01 → 2023-06-30−¥151m
Reconciling Itemsreconcilingsegment profit2023-04-01 → 2023-06-30−¥310m
jpcrp040300-q1r_E21902-000Foodreportable segmentrevenue2023-04-01 → 2023-06-30¥218.7bn
jpcrp040300-q1r_E21902-000Foodreportable segmentrevenue external2023-04-01 → 2023-06-30¥218.6bn
jpcrp040300-q1r_E21902-000Foodreportable segmentrevenue intersegment2023-04-01 → 2023-06-30¥147m
jpcrp040300-q1r_E21902-000Foodreportable segmentsegment profit2023-04-01 → 2023-06-30¥15.2bn
jpcrp040300-q1r_E21902-000Pharmaceuticalsreportable segmentrevenue2023-04-01 → 2023-06-30¥44.2bn
jpcrp040300-q1r_E21902-000Pharmaceuticalsreportable segmentrevenue external2023-04-01 → 2023-06-30¥44.2bn
jpcrp040300-q1r_E21902-000Pharmaceuticalsreportable segmentrevenue intersegment2023-04-01 → 2023-06-30¥3m
jpcrp040300-q1r_E21902-000Pharmaceuticalsreportable segmentsegment profit2023-04-01 → 2023-06-30¥4.6bn
Total Of Reportable Segments And Otherssegment totalrevenue2023-04-01 → 2023-06-30¥262.9bn
Total Of Reportable Segments And Otherssegment totalrevenue external2023-04-01 → 2023-06-30¥262.7bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2023-04-01 → 2023-06-30¥151m
Total Of Reportable Segments And Otherssegment totalsegment profit2023-04-01 → 2023-06-30¥19.8bn
Reconciling Itemsreconcilingrevenue2022-04-01 → 2022-06-30−¥140m
Reconciling Itemsreconcilingrevenue intersegment2022-04-01 → 2022-06-30−¥140m
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-06-30−¥278m
jpcrp040300-q1r_E21902-000Foodreportable segmentrevenue2022-04-01 → 2022-06-30¥204.4bn
jpcrp040300-q1r_E21902-000Foodreportable segmentrevenue external2022-04-01 → 2022-06-30¥204.3bn
jpcrp040300-q1r_E21902-000Foodreportable segmentrevenue intersegment2022-04-01 → 2022-06-30¥131m
jpcrp040300-q1r_E21902-000Foodreportable segmentsegment profit2022-04-01 → 2022-06-30¥14.5bn
jpcrp040300-q1r_E21902-000Pharmaceuticalsreportable segmentrevenue2022-04-01 → 2022-06-30¥42.9bn
jpcrp040300-q1r_E21902-000Pharmaceuticalsreportable segmentrevenue external2022-04-01 → 2022-06-30¥42.9bn
jpcrp040300-q1r_E21902-000Pharmaceuticalsreportable segmentrevenue intersegment2022-04-01 → 2022-06-30¥9m
jpcrp040300-q1r_E21902-000Pharmaceuticalsreportable segmentsegment profit2022-04-01 → 2022-06-30¥3.8bn
Total Of Reportable Segments And Otherssegment totalrevenue2022-04-01 → 2022-06-30¥247.3bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-04-01 → 2022-06-30¥247.1bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2022-04-01 → 2022-06-30¥140m
Total Of Reportable Segments And Otherssegment totalsegment profit2022-04-01 → 2022-06-30¥18.3bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 498
ItemContextValueUnit
Provision for bonusesCurrentQuarterInstant6733000000JPY
Other clPrior1YearInstant62478000000JPY
Other clCurrentQuarterInstant67815000000JPY
Current liabilitiesPrior1YearInstant266258000000JPY
Current liabilitiesCurrentQuarterInstant291388000000JPY
Bonds payablePrior1YearInstant10000000000JPY
Bonds payableCurrentQuarterInstant10000000000JPY
Long term loans payablePrior1YearInstant39496000000JPY
Long term loans payableCurrentQuarterInstant38591000000JPY
Deferred tax liabilitiesPrior1YearInstant5497000000JPY
Deferred tax liabilitiesCurrentQuarterInstant5991000000JPY
Net defined benefit liabilityPrior1YearInstant56255000000JPY
Net defined benefit liabilityCurrentQuarterInstant56467000000JPY
Provision for directors retirement benefitsPrior1YearInstant76000000JPY
Provision for directors retirement benefitsCurrentQuarterInstant70000000JPY
Other nclPrior1YearInstant7322000000JPY
Other nclCurrentQuarterInstant7168000000JPY
Noncurrent liabilitiesPrior1YearInstant118647000000JPY
Noncurrent liabilitiesCurrentQuarterInstant118288000000JPY
LiabilitiesPrior1YearInstant384905000000JPY
LiabilitiesCurrentQuarterInstant409676000000JPY
Capital stockPrior1YearInstant30000000000JPY
Capital stockCurrentQuarterInstant30000000000JPY
Capital surplusPrior1YearInstant80609000000JPY
Capital surplusCurrentQuarterInstant72221000000JPY
Retained earningsPrior1YearInstant602042000000JPY
Retained earningsCurrentQuarterInstant600394000000JPY
Treasury stockPrior1YearInstant-47502000000JPY
Treasury stockCurrentQuarterInstant-39119000000JPY
Shareholders equityPrior1YearInstant665149000000JPY
Shareholders equityCurrentQuarterInstant663495000000JPY
Valuation difference on available for sale securitiesPrior1YearInstant31598000000JPY
Valuation difference on available for sale securitiesCurrentQuarterInstant37730000000JPY
Deferred gains or losses on hedgesPrior1YearInstant11000000JPY
Deferred gains or losses on hedgesCurrentQuarterInstant332000000JPY
Foreign currency translation adjustmentPrior1YearInstant17870000000JPY
Foreign currency translation adjustmentCurrentQuarterInstant23126000000JPY
Remeasurements of defined benefit plansPrior1YearInstant-2713000000JPY
Remeasurements of defined benefit plansCurrentQuarterInstant-2653000000JPY
Valuation and translation adjustmentsPrior1YearInstant46767000000JPY
Valuation and translation adjustmentsCurrentQuarterInstant58536000000JPY
Non controlling interestsPrior1YearInstant39394000000JPY
Non controlling interestsCurrentQuarterInstant40033000000JPY
Net assetsPrior1YearInstant751311000000JPY
Net assetsCurrentQuarterInstant762066000000JPY
Liabilities and net assetsPrior1YearInstant1136217000000JPY
Liabilities and net assetsCurrentQuarterInstant1171743000000JPY
Net salesPrior1YTDDuration247131000000JPY
Net salesCurrentYTDDuration262734000000JPY
Cost of salesPrior1YTDDuration174143000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2023-03-31pass rounding
balance sheet identityconsolidated 2023-06-30pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2023-03-31pass
statement vs summary · net assetsconsolidated 2023-06-30pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-06-30pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-06-30pass
statement vs summary · operating cash flowconsolidated 2022-04-01/2022-06-30pass
statement vs summary · operating cash flowconsolidated 2023-04-01/2023-06-30pass
statement vs summary · revenueconsolidated 2022-04-01/2022-06-30pass
statement vs summary · revenueconsolidated 2023-04-01/2023-06-30pass
statement vs summary · total assetsconsolidated 2023-03-31pass
statement vs summary · total assetsconsolidated 2023-06-30pass